Clinical Trials Browser

INDUSTRY × belotecan × Gynecologic × Clear all

NCT01630018 2016-09-22

Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial

Phase 2 Completed

Carcinoma, Ovarian Epithelial